Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary ...

Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension ...

For recently diagnosed pulmonary arterial hypertension (PAH), adding sotatercept (Winrevair) to standard care lowered the ...

About Kaia Health Kaia Health is a global leader in digital therapeutics, providing evidence-based programs for chronic disease management. Its clinically validated Kaia Breathe solution brings ...

Pulmonary arterial hypertension (PAH) continues to be a condition associated with a high morbidity and mortality despite the advances in treatment ...

Pulmonary fibrosis is a lung disease where the air sacs and tissue in the lungs get stiff and scarred. This makes it harder to breathe and perform everyday activities. The ...

Mucoactive agents did little to stave off pulmonary exacerbations of non-cystic fibrosis bronchiectasis, the CLEAR trial ...

On World Lung Day 2025, understand how to keep your lungs healthy and prevent respiratory problems. For expert insights, we ...

1 Royal Brompton & Harefield Hospitals, Guy’s and St.Thomas’ NHS Foundation Trust, London, UK Since the Guideline, there is deeper understanding of referral characteristics, outcome measures, patient ...

Pulmonary function tests for the early diagnosis of chronic obstructive pulmonary disease will be included in Korea's national health screening program for the first time next year.

The Social Security Administration has tasked the National Academies of Sciences, Engineering, and Medicine to review the latest published research and science and produce a report addressing best ...

Content by Health System. With Asthma Peak Week typically during the middle of September, now is a great time to learn the ...